Pharmaceutical Business review

Lubrizol Q3 revenues increase

Lubrizol has posted a net income of $211.8m for the third quarter 2010, or $3.08 per diluted share, compared to $170.5m, or $2.46 per diluted share, for the comparable period in 2009.

For the nine months ended 30 September 2010, Lubrizol has posted a revenue of $4.1bn, compared to $3.4bn for the year ago period.

For the nine months ended 30 September 2010, Lubrizol net income was $575.5m, or $8.28 per diluted share, compared to $366.6m, or $5.34 per diluted share, for the year ago period.

Lubrizol CEO James Hambrick said that they were on track with where they expected to be at this point in the year.

"Excluding the impacts from tax benefits and the 2009 insurance recovery, we outperformed last year, which was at the time a record quarter for the company," Hambrick said.